Spero Therapeutics Inc. (SPRO) Fundamentals

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
SHARE INFORMATION
Market Cap$ 94,750,177
Shares Outstanding51,776,053
Float46,468,785
Percent Float89.75%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 18,256,000
Latest Fiscal EPS$ -2.91
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions224
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months2,964,938
Institutional Holdings Percent44.0%
Institutional Sold Previous 3 Months6,164,998
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months315,000
Insider Holdings Percent1.8
Insider Sold Previous 3 Months1,901,796
Insider Shares Owned933,227
TRADING INFO
52 Week High$ 16.30
52 Week Low$ 0.68
52 Week High Change$ -86.53
21 Day Moving Average$ 1.9162
21 Day Extended Moving Average$ 1.9054
50 Day Moving Average$ 1.944
50 Day Extended Moving Average$ 1.8251
200 Day Moving Average$ 2.8791
200 Day Extended Moving Average$ 3.7369
10 Day Average Volume317,910
20 Day Average Volume777,396
30 Day Average Volume692,356
50 Day Average Volume1,550,964
Alpha0.002084
Beta0.7597
Standard Deviation0.294072
R20.018899
7 Day Price Change$ -0.10
7 Day Percent Change-5.18%
21 Day Price Change$ -0.05
21 Day Percent Change-2.66%
30 Day Price Change$ -0.06
30 Day Percent Change-3.17%
Month to Date Price Change$ -0.11
Month to Date Percent Change-5.67%
Quarter to Date Price Change$ -0.17
Quarter to Date Percent Change-8.5%
180 Day Price Change$ 0.70
180 Day Percent Change61.95%
200 Day Price Change$ 0.45
200 Day Percent Change32.61%
Year to Date Price Change$ -14.18
Year to Date Percent Change-88.57%

Spero Therapeutics Inc. (SPRO) Key Ratios

PROFITABILITY
EBIT Margin-554.0%
EBITDA Margin-548.8%
Pre-Tax Profit Margin-1,061.3%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 4,969,000
Revenue Per Share$ 0.096
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.00
Total Debt To Equity0.20
Int Coverage-21.50
Current Ratio3.30
Leverage Ratio2.00
Quick Ratio3.20
Long Term Debt To Capital0.14
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 54,311,740
Price to Sales19.0683
Price to Free Cash-1.20
PE High Last 5 Years-1.00
Price To Book3.00
Price To Cash Flow0.00
PE Low Last 5 Years-3.30
Price to Tangible Book3.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.50
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-97.94
Return on Equity-141.89
Return on Capital-124.09

Spero Therapeutics Inc. (SPRO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOAnkit Mahadevia
Emplyoees41
Last AuditUE
CIK0001701108
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address675 Massachusetts Avenue
14th Floor
Cambridge, MA 2139
Websitehttps://www.sperotherapeutics.com
Facsimile-
Telephone+1 857 242-1600
EmailIR@sperotherapeutics.com


Your Recent History
NASDAQ
SPRO
Spero Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.